DRUGS & PHARMA
Gland Pharma to invest ₹400 crore for expanding Hyderabad capacity.

Gland Pharma to invest ₹400 crore for expanding Hyderabad capacity.

Gland Pharma will be investing over ₹400 crore in adding up capabilities to their existing facility in the Genome Valley he to manufacture biologicals, biosimilar, antibodies and recombinant Insulin. The company will recrureit... Full Story

"Sadhana Nitro Granted Environmental Clearance for Paracetamol Ingredient Production"

In a significant development, Sadhana Nitro Chem Ltd has obtained environmental regulatory clearance to produce pAP (Para Aminophenol), a crucial... Full Story

Browse All News by Date

Bangalore: Biocon plans to invest $161 million (Rs 725 crore) in Malaysia by 2014 to establish a biomanufacturing and research... Full Story

More Top Stories

LATEST HEADLINES FROM MIDDLE EAST AND NORTH AFRICA
OUR OTHER PRODUCTS & SERVICES: Projects Database | Tenders Database | About Us | Contact Us | Terms of Use | Advertise with Us | Privacy Policy | Disclaimer | Feedback

This site is best viewed with a resolution of 1024x768 (or higher) and supports Microsoft Internet Explorer 4.0 (or higher)
Copyright © 2016-2024

Technology Partner - Pairscript Software